CHRISTOPHER MOGREN: Open Payments
NPI 1417147927 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,135 in 73 payments from 10 companies in 2025. Trend: 2023 $1,151 · 2024 $1,427 · 2025 $2,135
Food & beverage: $2,124Education: $10
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $477 |
| Janssen Biotech, Inc. | 10 | $423 |
| ABBVIE INC. | 14 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $253 |
| Aimmune Therapeutics, Inc. | 6 | $145 |
| Ardelyx, Inc. | 11 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 2 | $123 |
| GENZYME CORPORATION | 3 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, ENTYVIO, DUPIXENT, ZENPEP, IBSRELA, VOQUEZNA.
Industry payments across IL — which companies pay providers there.
